Device Trial Radar · NCT03728985
Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms
Last checked: Nov 19, 2026Latest source record: Sep 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
102
Actual
Start
Jun 17, 2019
Primary completion
Jan 4, 2023
Study completion Jan 2030
Sponsor
- Lead sponsor
- W.L.Gore & AssociatesNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 2, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, non-randomized, , multicenter study with two independent arms: * Primary Study Arm - TAAA and Pararenal aneurysms requiring only TAMBE System. Hypothesis-driven analysis. * Up to 65 additional subjects may be implanted in Continued Access Phase under the Primary Study Arm only * Secondary Study Arm - TAAA requiring TAMBE System and CTAG Device(s). Non hypothesis-driven analysis. Minimum: 122 implanted subjects. Maximum: 202 implanted subjects with up to 65 additional subjects implanted in Continued Access (Primary Study arm)
Conditions
- Thoracoabdominal Aortic Aneurysm
Interventions
GORE EXCLUDER Thoracoabdominal Branch EndoprosthesisDevice
Endovascular Aortic Stent-Graft
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent of Subjects With Uncomplicated Technical Success and Freedom From Procedural Safety Composite EventTime frame: From start of Index Procedure to 59 Days Post Procedure
- Percent of Subjects Free From Clinically Significant Reintervention / Lesion-Related MortalityTime frame: 12 Months
Locations
44 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Mayo Clinic Arizona
Scottsdale, Arizona
Keck Medical Center of USC
Los Angeles, California
41 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.